I think this cooperation between Quagen and Neuron23 implies that introduction of biomarker and CDx is expanding to various therapeutic areas beyond oncology.
- Onco was study area where all the innovative CDx and personalized treatment were firstly introduced, but now we’re seeing the change in other therapeutic areas.
The CEO of Neuron23 achieved big investment from Softbank Vision Fund bases on this personalized therapy strategy in neuroimmunology area and machine learning tech.
Howevere there is limited info. about NEU-723 is open on the web, so I am not confident about the efficacy, safety and some other key factors in drug discovery.
+ LRRK2 mutation is the most dominant pathway of Parkinsons’s disease.
References: https://www.fiercebiotech.com/medtech/qiagen-tapped-develop-companion-diagnostic-neuron23-parkinsons-drug
Qiagen tapped to develop companion diagnostic for Neuron23's drug for Parkinson’s disease
Earlier this year, up-and-coming biotech Neuron23 nominated its first clinical candidate, a small-mol | As Neuron23's drug development continues, Qiagen will get started on building a companion diagnostic that’ll be able to predict how responsive Parkins
www.fiercebiotech.com
A Link between Autophagy and the Pathophysiology of LRRK2 in Parkinson's Disease
www.hindawi.com
https://neuron23.com/our-science/
Neuron23
Parkinson’s Disease The second most common neurodegenerative disease, Parkinson's leads to a gradual breakdown of dopaminergic neurons in the brain and a loss of dopamine, leading to impaired movement and other symptoms. It is characterized by bradykines
neuron23.com
$100M Richer, Neuron23 Introduces LRRK2 inhibitor for Parkinson's | BioSpace
Neuron23 announced today that it closed a $100 million Series C financing round led by SoftBank Vision Fund 2.
www.biospace.com
'일 > 제약 바이오' 카테고리의 다른 글
| Safety와 Tolerability의 차이 (feat. Chat GPT) (0) | 2023.07.04 |
|---|---|
| 고양이 관절염 항체 치료제 Solensia (FDA 최초로 승인한 동물용 항체 치료제) (0) | 2022.09.22 |
| Acute pain 신약 개발 업체 Heron Therapeutics, 두 개 약물의 FDA 승인 (0) | 2022.09.21 |
| NK cell (Natural killer cell)을 활성화시키는 Combi. therapy (0) | 2022.06.24 |
| Precision BioSciences의 유전자 편집 기술이 CRISPR의 대항마 될까? (0) | 2022.05.27 |